HCG acquires oncology hospital lab, clinical trials business from Strand Lifesciences

04 Sep 2021 Evaluate

HealthCare Global Enterprises (HCG) has acquired oncology hospital labs and clinical trials business from Strand Lifesciences as well as simultaneous the company divested its 38.5% stake (on paid-up capital basis and 34.5% on fully diluted basis) in Strand to Reliance Industries group company.

HCG received consideration of around Rs 157 crore for sale of its ownership in Strand and acquired labs and clinical research business through a Business Transfer Agreement (BTA) from Strand for a consideration of Rs 81 crore with a set-off of Rs 7 crore towards receivables. The transactions resulted in net cash inflow of Rs 83 crore for HCG in addition to the take-over of the labs and clinical research business.

The company is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann’ brand.

HealthcareGlobal Share Price

498.45 -0.15 (-0.03%)
15-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6694.40
Max Healthcare Inst 1039.35
Narayana Hrudayalay 1287.85
Aster DM Healthcare 489.85
Global Health 1023.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.